Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

• Combined Oral Contraceptive Therapy in Women with Posterior Deep Infiltrating Endometriosis via openalex
• Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis via openalex
• Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study via openalex
• Current Strategies for Endometriosis Management via openalex
• Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis via openalex
• Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
• Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis via openalex
• Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density via openalex
• Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months via openalex
• Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial via openalex
• Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. via openalex
• Levonorgestrel‐releasing intrauterine system (Mirena ^® ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex
• Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex
• Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women via openalex
• Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas via openalex
• Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence via openalex
• Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention via openalex
• Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest via openalex
• Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
• The effectiveness of laparoscopic excision of endometriosis via openalex
• The effect of second‐line surgery on reproductive performance of women with recurrent endometriosis: A systematic review via openalex
• Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
• W6670763327 via openalex
• W2021687464 via openalex
• W2045458073 via openalex
• W2068643120 via openalex
• W2071361972 via openalex
• W2079805354 via openalex
• W2080162691 via openalex
• W2101417341 via openalex
• W2134778793 via openalex
• W6605536619 via openalex
• W6655287665 via openalex

Cited by (13)

• LONG-TERM OUTCOMES OF PHARMACOLOGICAL VERSUS SURGICAL TREATMENT IN WOMEN WITH ENDOMETRIOSIS: IMPACT ON RECURRENCE AND QUALITY OF LIFE — A REVIEW ARTICLE 2026
• Short-term safety of dienogest on bone mineral density in Iranian women with endometriosis: A cross-sectional study 2026
• Ureteral endometriosis post-hysterectomy for adenomyosis: a case report and literature review 2025
• Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis 2024
• A systematic review and Bayesian analysis of the adverse effects of dienogest 2024
• Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest 2022
• Computational Drug Discovery in Patients with Endometriosis-Induced Infertility via Text Mining and Biomedical Databases 2022
• The dienogest-related cystitis in women with endometriosis: a prospective, controlled, comparative study 2022
• The Long-Term Effect of Dienogest on Bone Mineral Density After Surgical Treatment of Endometrioma 2021
• Computational Drug Discovery in Patients with Endometriosis-Induced Infertility via Text Mining and Biomedical Databases 2021
• Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review 2021
• The recurrence rate of ovarian endometrioma in women aged 40–49 years and impact of hormonal treatment after conservative surgery 2020
• Discerning Endometriosis as a Multifaceted Entity: A Comprehensive Review 2020

Source provenance

europepmc

last seen: 2026-06-21T06:12:49.409960+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:22:54.901233+00:00